Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 276-300 of 492 matching filings.

Per page
25
Current page
12
S-8 POS File 333-260323

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-253912

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-264187

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-262533

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-265731

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-257858

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-253925

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
20 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
14 Sep 2022
Reporting date
09 Sep 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
08 Sep 2022
Reporting date
08 Sep 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
26 Aug 2022
Reporting date
19 Aug 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
11 Aug 2022
Reporting date
10 Aug 2022
Next action
Verify source filing
4

4 filing

Filing date
10 Aug 2022
Reporting date
10 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
26 Jul 2022
Reporting date
25 Jul 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
20 Jul 2022
Reporting date
15 Jul 2022
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
18 Jul 2022
Reporting date
11 Jul 2022
Next action
Verify source filing
424B3 File 333-265731

PROSPECTUS

Filing date
06 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265731

EFFECT filing

Filing date
29 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-265731

AMENDMENT NO. 1 TO FORM S-1

Filing date
24 Jun 2022
Reporting date
Not listed
Next action
Verify source filing
8-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 8-K

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
22 Jun 2022
Reporting date
17 Jun 2022
Next action
Verify source filing
S-1 File 333-265731

REGISTRATION STATEMENT

Filing date
21 Jun 2022
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
16 Jun 2022
Reporting date
14 Jun 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .